α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration.
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration.
复制标题
DOI:
10.1186/s40478-017-0494-9
复制
发表时间:
2017-11-21
影响因子:
7.1
通讯作者:
West AB
中科院分区:
文献类型:
--
作者:
Harms AS;Delic V;Thome AD;Bryant N;Liu Z;Chandra S;Jurkuvenaite A;West AB
Genetic variation in a major histocompatibility complex II (MHCII)-encoding gene (HLA-DR) increases risk for Parkinson disease (PD), and the accumulation of MHCII-expressing immune cells in the brain correlates with α-synuclein inclusions. However, the timing of MHCII-cell recruitment with respect to ongoing neurodegeneration, and the types of cells that express MHCII in the PD brain, has been difficult to understand. Recent studies show that the injection of short α-synuclein fibrils into the rat substantia nigra pars compacta (SNpc) induces progressive inclusion formation in SNpc neurons that eventually spread to spiny projection neurons in the striatum. Herein, we find that α-synuclein fibrils rapidly provoke a persistent MHCII response in the brain. In contrast, equivalent amounts of monomeric α-synuclein fail to induce MHCII or persistent microglial activation, consistent with our results in primary microglia. Flow cytometry and immunohistochemical analyses reveal that MHCII-expressing cells are composed of both resident microglia as well as cells from the periphery that include monocytes, macrophages, and lymphocytes. Over time, α-Synuclein fibril exposures in the SNpc causes both axon loss as well as monocyte recruitment in the striatum. While these monocytes in the striatum initially lack MHCII expression, α-synuclein inclusions later form in nearby spiny projection neurons and MHCII expression becomes robust. In summary, in the rat α-synuclein fibril model, peripheral immune cell recruitment occurs prior to neurodegeneration and microglia, monocytes and macrophages all contribute to MHCII expression. The online version of this article (10.1186/s40478-017-0494-9) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.3233/jpd-150691
发表时间:
2016
期刊:
Journal of Parkinson's disease
影响因子:
--
作者:
Bousset L;Brundin P;Böckmann A;Meier B;Melki R
通讯作者:
Melki R
影响因子:
30.5
作者:
Goldmann T;Wieghofer P;Jordão MJ;Prutek F;Hagemeyer N;Frenzel K;Amann L;Staszewski O;Kierdorf K;Krueger M;Locatelli G;Hochgerner H;Zeiser R;Epelman S;Geissmann F;Priller J;Rossi FM;Bechmann I;Kerschensteiner M;Linnarsson S;Jung S;Prinz M
通讯作者:
Prinz M
影响因子:
21.3
作者:
Fujiwara, H;Hasegawa, M;Iwatsubo, T
通讯作者:
Iwatsubo, T
DOI:
10.4049/jimmunol.1100421
发表时间:
2012-01-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Mizutani M;Pino PA;Saederup N;Charo IF;Ransohoff RM;Cardona AE
通讯作者:
Cardona AE
DOI:
10.1126/science.1227157
发表时间:
2012-11-16
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Luk KC;Kehm V;Carroll J;Zhang B;O'Brien P;Trojanowski JQ;Lee VM
通讯作者:
Lee VM